Title
Category
Credits
Event date
Cost
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will review the current state of HTx for pediatric CHD, addressing issues such as mortality risk factors, waitlist mortality, mechanical-support options, and immunosuppression and antibody-mediated rejection. It will also discuss key issues for this population, including psychosocial challenges, rehabilitation goals and future expectations regarding functional outcomes.
  • Disease management
  • Rare diseases
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 CDR - Dietitians
  • 1.25 ASWB - Social Workers
$0.00
This activity will explore the latest approaches and tools for diagnosing and managing rare diseases. It will delve into cutting-edge genetic-sequencing technologies and advanced data analytics that can assist and guide diagnosis. Participants will also learn about interdisciplinary teams and patient advocacy and the impact they have on solving these complex medical problems.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will examine the current state of care for CKD, including recent advancements and interventions that can slow CKD progression and preserve kidney function and strategies to optimize care pathways for managing CKD and its common comorbidities.
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will discuss the latest advances in AD diagnosis and management, including biomarkers, imaging techniques and cognitive assessments. Emerging pharmacological therapies that target the underlying disease and novel approaches to optimizing patient care will be highlighted.
  • Disease management
  • Health equity
  • 1.00 AAFP - Family Physicians
  • 1.00 ABIM MOC - Physicians
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity aims to enhance participants’ comprehension of race-based adjustments in clinical algorithms and increase competency in race-neutral and impartial interpretation of PFTs.
  • Behavioral health
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 Attendance - General Attendance
$0.00
This E-newsletter will provide an overview of the program, including details regarding the benefits of LAI atypical antipsychotics and other available agents, a brief review of schizophrenia and potential clinical steps. Additional information regarding the retrospective drug utilization review process and the rationale for brand drug preference will also be highlighted.
  • Oncology
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 PRC - Philippine Council of Nursing
  • 1.00 ASWB - Social Workers
$0.00
This activity will provide participants with an overview of early BC diagnosis and its impact on survival rates. It will explore recently approved therapies for BC both as standalone treatments and in combination with established therapeutic approaches. Emerging therapies and their potential benefits will be examined, and the value of biomarkers will be discussed. Participants will gain insight into treatment strategies to optimize patient outcomes in BC.
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will examine the scope, impact, key statistics and factors contributing to the opioid crisis and highlight the current recommended opioid prescribing guidelines, their challenges and the role of state prescription drug monitoring programs (PDMP). Strategies to aid in implementing the opioid prescribing guidelines and to mitigate the opioid crisis will also be discussed.
  • Disease management
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 Attendance - General Attendance
$0.00
This podcast will provide an overview of updated approaches to UTI detection, diagnosis and treatment; review common uropathogens; and highlight the distinctive challenges of UTIs related to infection characteristics and complications. Experts will share valuable insights through a discussion of evidence-based strategies to manage and prevent UTIs effectively.
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will provide an overview of obesity and diabetes that describes effective multi-interventional approaches to weight loss and, importantly, highlights the role of incorporated lifestyle changes in promoting the likelihood of weight loss success and improved health outcomes. The conversational style of this activity will encourage discussion around obesity-care planning and examine the factors that must be considered due to the chronic and relapsing characteristics of this disease.

Pages